IRON
Disc Medicine·NASDAQ
--
--(--)
--
--(--)
5.01 / 10
Netural
Analysts are overwhelmingly positive (28.6% Strong Buy, 71.4% Buy) but weighted rating is low (2.07) and price fell 1.31%. Fund‑flow score is 7.96, with small‑investor inflow positive and larger‑size inflows negative.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
29%
Buy
71%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-27
InstitutionTruist Securities
Times predicted3
Historical Win Rate33.3%
What is the analyst consensus for IRON?
- IRON holds a Bearish analyst rating, with 71% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.01/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
